{
    "address": "Klara Norra Kyrkogata 33",
    "city": "Stockholm",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W5304G127",
    "description": "Karo Pharma AB engages in the sale and marketing of products for everyday healthcare. The company is headquartered in Stockholm, Stockholm and currently employs 243 full-time employees.  The Company\u2019s pipeline comprises three projects: Estrogen Receptor Beta (ERbeta) cancer, a platform, which focuses on the development of ERbeta in cancer treatment; ERbeta multiple sclerosis (MS), which specializes in the autoimmune disease MS treatment; and Related Orphan Receptor Gamma (RORgamma), which is responsible for the nuclear receptors application in treatment of autoimmune disease, such as rheumatoid arthritis and psoriasis. The firm collaborates with Pfizer, 4D Science, and Merck, among others. Its trademarks portfolio includes Karo Bio, BioKey, BioKey Assay and Molecular Braille. The firm operates Karo Bio Research AB, Karo Bio Discovery AB, Kommanditbolaget Odenplan Fastigheter, Tanomed AB, MedCore AB and Medireduce AB as subsidiaries.",
    "employeeTotal": "243.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Pharmaceuticals",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Pharmaceuticals",
    "gsector": "Health Care",
    "gsubind": "Pharmaceuticals",
    "ipo": "1998-04-03",
    "isin": "SE0007464888",
    "logo": "https://finnhub.io/api/logo?symbol=KARO.ST",
    "marketCapitalization": 13344.47,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Pharmaceutical Preparation Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Karo Pharma AB",
    "phone": "46103302310",
    "sedol": "BYYK0P8",
    "shareOutstanding": 221.497,
    "state": "STOCKHOLM",
    "ticker": "KARO.ST",
    "weburl": "https://www.karopharma.se/"
}